![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0399|69|1|82-84
ISSN: 0042-1138
Source: Urologia Internationalis, Vol.69, Iss.1, 2002-07, pp. : 82-84
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling
THE PROSTATE, Vol. 78, Iss. 3, 2018-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients
Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Management of T1G3 Bladder Cancer
Urologia Internationalis, Vol. 69, Iss. 4, 2002-11 ,pp. :